R&D dosage forms

Jubilant’s finished dosage forms R&D center in Delhi, India is a state-of-art centre, equipped with the latest instrumentation.

A total team of more than 100 scientists works in dedicated groups, focused on:

• IR products: coated/ uncoated tablets, bi-layered tablets, hard gelatin capsules, powder for oral suspensions
• NDDS platforms: extended/ delayed/ sustained release, orally disintegrating and chewable tablets

Therapeutic categories in focus are the central nervous system, cardiovascular system, anti-infective, respiratory and anti-diabetics. Over 60 projects in various stages of development are handled simultaneously while identification of new projects for development is a constant process.